Central Valley Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,576
Closed -$1.49M 141
2025
Q1
$1.49M Buy
6,576
+394
+6% +$86.7K 0.56% 55
2024
Q4
$1.27M Buy
6,182
+609
+11% +$134K 0.58% 48
2024
Q3
$1.35M Buy
5,573
+164
+3% +$38.4K 0.76% 39
2024
Q2
$1.82M Buy
5,409
+220
+4% +$47.8K 0.78% 33
2024
Q1
$1.17M Buy
5,189
+582
+13% +$131K 0.6% 48
2023
Q4
$1.01M Buy
+4,607
New +$974K 0.6% 52

Other funds holding STE

Central Valley Advisors's STE Position: Q2 2025 in Review

Central Valley Advisors sold out of Steris (STE) in Q2 2025, closing a stake of 6,576 shares — an estimated $1.49M sold.

Central Valley Advisors first reported a position in STE in Q4 2023 and held it in 6 quarters. The position peaked at $1.82M in Q2 2024. 836 funds tracked by Wall St. Rank hold STE as of Q2 2025.

  • Central Valley Advisors reported no remaining Steris position as of Q2 2025 after selling out during the quarter.
  • Central Valley Advisors sold 6,576 Steris shares in Q2 2025, an estimated $1.49M.
  • Central Valley Advisors first reported a position in Steris in Q4 2023 and held it in 6 quarters.
  • Central Valley Advisors's Steris position peaked at $1.82M in Q2 2024.
  • 836 funds tracked by Wall St. Rank held Steris as of Q2 2025.

Based on Central Valley Advisors's 13F filing for Q2 2025, filed 9 Jul 2025.